Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database
Authors
Keywords
Thalidomide, Lenalidomide, Serious adverse drug reactions
Journal
MEDICAL ONCOLOGY
Volume 30, Issue 4, Pages -
Publisher
Springer Nature
Online
2013-09-27
DOI
10.1007/s12032-013-0733-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Second malignancies after multiple myeloma: from 1960s to 2010s
- (2012) A. Thomas et al. BLOOD
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Philip L. McCarthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France?
- (2012) Marie-Noelle Paludetto et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Lenalidomide treatment for patients with multiple myeloma: Diagnosis and management of most frequent adverse events
- (2011) Ernesto Pérez Persona et al. ADVANCES IN THERAPY
- Practical management of adverse events in multiple myeloma: Can therapy be attenuated in older patients?
- (2011) Antonio Palumbo et al. BLOOD REVIEWS
- Lenalidomide: an update on evidence from clinical trials
- (2010) Meletios-Athanassios Dimopoulos et al. BLOOD REVIEWS
- Lenalidomide mode of action: linking bench and clinical findings
- (2010) Faith Davies et al. BLOOD REVIEWS
- Management of treatment-related adverse events in patients with multiple myeloma
- (2010) María-Victoria Mateos CANCER TREATMENT REVIEWS
- Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations
- (2010) B. Mohty et al. HAEMATOLOGICA
- Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
- (2010) Michel Delforge et al. LANCET ONCOLOGY
- Management of disease- and treatment-related complications in patients with multiple myeloma
- (2010) Francesca Gay et al. MEDICAL ONCOLOGY
- Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report
- (2009) Wan Kyu Eo et al. ANNALS OF HEMATOLOGY
- Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia
- (2009) R. Pal et al. BLOOD
- Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
- (2009) F. Gay et al. BLOOD
- Multiple myeloma: management of adverse events
- (2009) F. Gay et al. MEDICAL ONCOLOGY
- Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
- (2008) Antonio Palumbo et al. BLOOD REVIEWS
- Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy
- (2008) Marianna Colagrande et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Erythema Multiforme/Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in Lenalidomide-Treated Patients
- (2008) Carmen P. Castaneda et al. JOURNAL OF CLINICAL ONCOLOGY
- Risque thromboembolique des thérapeutiques antiangiogéniques utilisées dans les cancers
- (2008) L. Drouet PATHOLOGIE BIOLOGIE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now